Ketoconazole and MK-2866 Interaction
Ketoconazole and MK-2866 have an interaction requiring monitoring for interaction with 51% confidence. Both Ketoconazole and MK-2866 carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. These compounds primarily affect different organ systems.
Compound Profiles
Ketoconazole
Antifungal | Topical Anti-Androgen for Hair Loss
Ketoconazole works through multiple pathways relevant to hair loss. As an azole antifungal, it inhibits the enzyme lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis and killing Malassezia fungi that colonize the scalp and contribute to inflammation and seborrheic dermatitis.
View full profileMK-2866
Selective Androgen Receptor Modulator | Muscle Wasting Research
MK-2866 binds to the androgen receptor (AR) with high affinity and selectivity, functioning as a partial agonist in muscle and bone tissue. Upon binding, the MK-2866-AR complex undergoes a conformational change that promotes nuclear translocation and interaction with androgen response elements (AREs) on DNA, activating transcription of genes involved in protein synthesis, nitrogen retention, and myogenic differentiation.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Ketoconazole with MK-2866?
Yes, but with caution. Both Ketoconazole and MK-2866 carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. Regular monitoring is advised.
Is Ketoconazole and MK-2866 safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: androgenic. Monitor accordingly.
What are the interactions between Ketoconazole and MK-2866?
Both Ketoconazole and MK-2866 carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time Ketoconazole and MK-2866?
Ketoconazole has a half-life of Topical application stays local with minimal systemic absorption and MK-2866 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.